Modulation of Irritation-Induced Increase of E-selectin mRNA In Vivo by Topically Applied Corticosteroids1  by Kukutsch, Nicole A. et al.
Modulation of Irritation-Induced Increase of E-selectin
mRNA In Vivo by Topically Applied Corticosteroids1
Nicole A. Kukutsch, Esther A. Coors, Matthias S. Gruschwitz, and Peter von den Driesch
Department of Dermatology, University of Erlangen-Nuremberg, Erlangen, Germany
There is a continuous need for methods to evaluate
the biologic effects of topically applied drugs in the
skin. Irritation of the epidermis with sodium dodecyl
sulfate leads to an upregulation of E-selectin on endo-
thelial cells and E-selectin mRNA can be detected
in vivo within a short time. This study was aimed to
investigate whether this biologic response can be used
as a read-out for the anti-inflammatory effect of topic-
ally administered corticosteroids. We investigated skin
of healthy volunteers treated according to the two
following experimental protocols: (i) topical applica-
tion of different corticosteroids (versus basic ointments
as controls) for 12 h and irritation with sodium dodecyl
sulfate 1% for 4 h; (ii) irritation with sodium dodecyl
sulfate 1% for 12 h and application of the corticostero-
ids for 5 h. The biopsy specimens were subjected to
RNA extraction and reverse transcription and compet-
itive reverse transcriptase–polymerase chain reaction
was performed using defined concentrations of a pre-
Irritation of the epidermis is a well-known model to studythe mechanisms of inflammation (Nickoloff and Naidu,1994). Immigration of leukocytes in tissues such as the skinis dependent on their attachment to activated endothelialcells (Springer, 1990). This has been shown to be a multistep
procedure involving the upregulation of cellular adhesion molecules
(Friedmann et al, 1993; Saito et al, 1993; Meagher et al, 1994).
Recent data suggest a crucial part for E-selectin to recruit P-
selectin glycoprotein ligand-1 expressing T cells into the inflamed
tissue (Austrup et al, 1997; Fuhlbrigge et al, 1997). Upregulation
of E-selectin on upper dermal vessels has been described to be an
early event after irritation of the epidermis (Friedmann et al, 1993)
and, in a pilot study, we found the presence of the corresponding
E-selectin mRNA as soon as 30 min after application of the irritant
and a maximum after 4 h (unpublished data). Because the amount
of E-selectin expression correlates with the extent of dermal
inflammation (von den Driesch et al, 1993; von den Driesch and
Simon, 1994; Henseleit et al, 1996), we questioned whether the
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constructed mimic DNA. As result, we found strong
positive signals for wild-type E-selectin mRNA in all
biopsies pretreated with basic ointments, whereas in
biopsies from areas pretreated with corticosteroids the
bands for wild-type E-selectin DNA could be detected
at 10–1000 lower levels of mimic DNA concentrations.
The reverse experiment, application of corticosteroids
after the irritation, again yielded significantly reduced
signals for E-selectin mRNA. In both experimental
settings, the different strength of the topical cortico-
steroids used was reflected by significant differences
in the amount of E-selectin mRNA found in the
biopsies. This study demonstrates the pharmacologic
effect of topical corticosteroids on the irritation-
induced E-selectin mRNA expression on dermal endo-
thelial cells in vivo using very small tissue samples and
this approach may be of value for further pharmaceut-
ical studies. Key words: barrier/ECAM-1/endothelial cells/
pharmacology. J Invest Dermatol 113:170–174, 1999
mRNA response for E-selectin could be useful to monitor the
effect of an anti-inflammatory drug in vivo. In other studies on the
effects of corticosteroid treatment in inflammatory disorders such
as allergic rhinitis, downregulation of VCAM-1 and E-selectin
proteins were shown by means of immunohistochemistry (Karlsson
and Hellquist, 1996). The regulation of E-selectin on mRNA level,
however, has not been used in this regard so far. Thus, this study
investigated the influence of topically applied corticosteroids on
irritation-induced E-selectin mRNA signals in vivo.
MATERIALS AND METHODS
Volunteers Thirty healthy volunteers, 17 male and 13 female, mean age
33, participated in this study. After written informed consent up to five
test areas on the skin of the back were chosen. The presence of any
inflammatory systemic or skin disease as well as any need for systemic or
topical anti-inflammatory therapy, and a history of sunburn 3 mo prior to
the experiment, were strictly used as exclusion criteria.
Test conditions The first set of experiments was carried out treating
four different areas on the back of healthy subjects. Area I was irritated for
4 h by applying 50 µl of sodium dodecyl sulfate (SDS) (1% in water) using
an occlusive Finn chamber patch test on Scanpore tape (Hermal, Reinbeck,
Germany), area II was pretreated with basic ointment (Dermatop basic
cream, Hoechst, Bad Soden, Germany) for 12 h before application of the
irritant for 4 h, area III was pretreated with 0.25% prednicarbate (Dermatop)
for 12 h, and area IV was left untreated. After removing the Finn chamber,
4 mm biopsies were obtained under local anesthesia. Epidermis and dermis
were separated after 45 s of microwave heating (490 W) and frozen at
70°C until use.
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Table I. Primers used in the study
Primer Direction Chosen sequence Length of amplification product
E-Selectin Upstream AGAAGAAGCTTGCCCTATGC 315 bp
Downstream AGGCTGGAATAGGAGCACTCCA
Upstream AGAAGAAGCTTGCCCTATGCCAGTGAAATCTCCTCCG 442 bp
Downstream AGGCTGGAATAGGAGCACTCCATCTGTCAATGCAGTTTGTAG
Table II. Results of competitive reverse transcriptase–PCR for E-selectin with different treatment conditionsa
amol per µl mimic DNA Area I Area II Area III Area IV
No pretreatment Pretreatment with basic Pretreatment with No pretreatment
SDS 4 h ointment SDS 4 h prednicarbate SDS 4 h No irritation
0
10/10
10–4
4/10
10–3
6/10
10–2
8/10 6/10
0.5 3 10–2 2/10 2/10
10–1 2/10
aSkin biopsy specimens were obtained from the back of healthy individuals. Area I was irritated with SDS 1% for 4 h, area II was pretreated for 12 h with a basic ointment
and irritated with SDS 1% for 4 h, area III with 0.25% prednicarbate for 12 h and with SDS for 4 h; area IV was not pretreated or irritated. After RNA extraction and
reverse transcription, competitive reverse transcriptase–PCR was performed using defined concentrations of a preconstructed mimic DNA. The results show a significant
(p . 0.001, Fisher’s exact test) increase in amounts of E-selectin mRNA in SDS-treated (areas I and II) versus SDS-untreated area IV and significant (p . 0.001, Fisher’s
exact test) decreases in E-selectin mRNA for SDS-pretreated and prednicarbate-pretreated area III compared with area I pretreated with SDS only and with area II pretreated
with SDS and basic ointment.
In the second set of experiments one area was treated with Unguentum
leniens (according to the Deutsche Rezept Formulierungen DRF) as basic
ointment and three other areas were treated with hydrocortisone acetate
0.4%, prednisolone 1%, and triamcinolone acetonide 0.1%, respectively,
each dissolved in Unguentum leniens, for 12 h. After that the areas were
treated with SDS 1% for 4 h before the biopsy specimens were done.
In the third series of experiments the test areas were treated with SDS
1% for 12 h, followed by an application of hydrocortisone acetate 0.4%,
prednisolone 1%, and triamcinolone acetonide 0.1%, each dissolved in
Unguentum leniens, and Unguentum leniens as control. After another 5 h the
biopsy specimens were taken.
Competitive reverse transcriptase–polymerase chain reaction
(PCR) Total RNA was extracted from upper dermal tissue using an
RNeasy Total RNA kit (Quiagen, Hilden, Germany). The dermal tissue
was thoroughly homogenized with a rotar-stator homogenizer (Ultra
Turrax T8, IKA Analyzentechnik GmbH, Staufen im Breisgau, Germany)
in 2 3 300 µl lysis buffer containing β-mercaptoethanol. The extraction
was then performed according to the user protocol. Total RNA was eluted
in 40 µl of diethylpyrocarbonate-treated water. The concentration and
purity of the RNA was determined by measuring the absorbance at 230,
260, 280, 320 nm using a 10 µl ultramicrocuvette (Gene Quant II,
Pharmacia Biotech, Freiburg, Germany). The ratio between the absorbance
values at 260 and 280 nm gave an estimate of RNA purity.
One hundred nanograms of RNA was subjected to 100 U of a Moloney
leukemia virus reverse transcriptase (GIBCO-BRL, Eggenstein, Germany)
in a reaction mixture containing 5 3 buffer, 0.1 M ditriothritol, 0.3 mM
deoxynucleotide triphosphates (Boehringer, Mannheim, Germany) and
360 pmol of random primer (GIBCO-BRL) for 60 min at 39°C. Afterwards,
competitive PCR was performed using a PCR Mimic Construction Kit
(Clontech, Palo Alto, CA). Composite E-selectin primers were designed
(Table I) and used in the PCR amplification with the mimic DNA
fragment provided with the kit. The templates were amplified and purified
according to the manufacturer’s instructions. Pure PCR mimics were then
quantitated and diluted from 103 amol per µl to 10–4 amol per µl and used
as competitive internal standards for quantitation of the E-selectin wild-
type DNA levels after reverse transcription. Primers for E-selectin were
used based on a previously published sequence (Saito et al, 1993) (Table I).
Afterwards, 2 µl of cDNA and 2 µl of mimic DNA were added to 45 µl
of a PCR mixture containing 10 3 buffer, MgCl2, dNTP, 11 pmol (each)
of E-selectin sense and anti-sense primers and 0.2 U DNA polymerase
(Eurogentec, Seraing, Belgium). The mixtures were covered with 50 µl
mineral oil (Roth, Karlsruhe, Germany) and amplification was performed
with 35 cycles in an Omni Gene temperature cycler (Hybaid, Teddington,
U.K.) with denaturation for 1 min at 94°C, annealing for 1 min at 55°C
and primer extension at 72°C. After amplification, 8 µl aliquots of each
reaction mixed with 1.5 µl loading buffer were subjected to electrophoresis
through a 2% agarose gel (Roth) and stained with ethidium bromide.
Restriction analysis of the E-selectin wild-type amplificate using PvuII
revealed the expected bands (205 bp and 83 bp, respectively) in the gel
electrophoresis (not shown). Bands were visualized under UV light and
photographed.
Evaluation Photographs were scanned and densitometry was performed
using ScanPack 2.0 software (Biometra, Go¨ttingen, Germany). Equal bands
for mimic and wild-type DNA indicated the corresponding wild-type
DNA concentration. If no equal bands could be detected, the value of
wild-type DNA was considered to be the 5-fold of the weaker mimic
DNA concentration. Statistical evaluation of the results was performed
using Fisher’s exact test.
RESULTS
Effect of prednicarbate on E-selectin mRNA expression In
the first series of experiments, E-selectin wild-type mRNA could
not be found in all biopsy specimens from the control area without
any treatment (Fig 1A, summary of results in Table II). In test
sites treated with SDS 1% for 4 h mRNA for E-selectin was found
in eight of 10 biopsy specimens at a dilution level of the mimic
DNA of 10–2 amol per µl and in two of 10 at 0.5 3 10–2 amol
per µl (Fig 1B).
In six of 10 biopsy specimens from the areas which were
pretreated with an identical basic ointment for 12 h and with SDS
1% for 4 h a similar amount of wild-type E-selectin amplificate
was found (Fig 1C). In two of 10 cases, the signal was equal to
0.5 3 10–2 amol per µl and the other two biopsy specimens
revealed a concentration equal to 10–1 amol per µl mimic DNA.
Thus both test sites treated with SDS showed a significant
(p , 0.001, Fisher’s exact test) upregulation of E-selectin mRNA
compared with the untreated test sites.
In six of 10 of the biopsy specimens derived from the areas
which were pretreated for 12 h with topically applied prednicarbate
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0.25% and for 4 h with SDS 1% an E-selectin mRNA concentration
equal to 10–3 amol mimic DNA per µl was found, whereas four
of 10 showed a concentration equal to 10–4 amol mimic DNA per
µl (Fig 1D). Thus significantly less mRNA for E-selectin was
found in the prednicarbate-pretreated test sites (significance
p , 0.001, Fisher’s exact test).
Comparison of hydrocortisone, prednisolone, and triamcin-
olone pretreatment In the second series of experiments, hydro-
cortisone acetate 0.4%, prednisolone 1.0%, and triamcinolone
acetonide 0.1% were dissolved in Unguentum leniens and their
inhibiting effect on SDS-induced E-selectin expression was com-
pared with the basic ointment and to each other. As a result (Table
III) we found that the effect of topical hydrocortisone compared
with the basic ointment did not reach significance, whereas
prednisolone and triamcinolone caused a significant (p , 0.001,
Fisher’s exact test) decrease in E-selectin mRNA levels compared
with basic ointment. Furthermore, comparison of triamcinolone
versus hydrocortisone revealed significant lower mRNA levels in
the triamcinolone-treated skin biopsy specimens (p , 0.01, Fisher’s
exact test), whereas comparison of prednisolone versus triamcinolone
and prednisolone versus hydrocortisone did not reach clear signific-
ance (p 5 0.33 and p 5 0.06, respectively, Fishers exact test).
Effect of hydrocortisone, prednisolone, and triamcinolone
treatment The reverse experiments, treating a skin site which
had been irritated for 12 h with SDS 1% with the three topical
corticosteroids, revealed similar results (Table IV). Prednisolone
1% and triamcinolone acetonide 0.1% significantly reduced the E-
Figure 1. Prednicarbate modulates irritation-
induced increase of E-selectin mRNA. Skin
biopsies from four differently treated test sites were
taken. After RNA extraction and reverse
transcription a competitive PCR was performed
using defined dilutions of a preconstructed mimic
DNA as the competitor. (A) Without any treatment
no signal for wild-type E-selectin could be detected.
(B) Test site treated with SDS 1% for 4 h revealed
a wild-type signal corresponding to a mimic DNA
concentration of 10–2 amol per µl. (C) Pretreatment
of the skin with the basic ointment for 12 h before
SDS application for another 4 h showed in two of
10 cases a signal equal to 0.5 3 10–2 amol per µl
mimic DNA. (D) After pretreatment with
prednicarbate 0.25% in an identical ointment and
application of SDS 1% for another 4 h six of 10
samples showed a level of 10–3 amol per µl mimic
DNA and four of 10 at a level of 10–4 amol per µl
mimic DNA.
Table III. Results of competitive reverse transcriptase–PCR for E-selectin with different treatment conditionsa
amol per µl mimic DNA Area I Area II Area III Area IV
Pretreatment with basic Pretreatment with Pretreatment with Pretreatment with
ointment SDS 4 h hydrocortisone 0.4% SDS 4 h prednisolone 1% SDS 4 h triamcinolone 0.1% SDS 4 h
0 3/10
6/10
10–4 3/10 5/10 4/10
10–3 2/10 4/10 2/10
10–2
6/10
3/10
0.5 3 10–2 2/10
10–1
aSkin biopsy specimens were obtained from the back of healthy individuals. Area I was pretreated for 12 h with a basic ointment and irritated with SDS 1% for 4 h, area
II with hydrocortisone 0.4%, area III with prednisolone 1.0%, and area IV with triamcinolone 0.1%. SDS 1% was then applied for 4 h. After RNA extraction and reverse
transcription, competitive reverse transcriptase–PCR was performed using defined concentrations of a preconstructed mimic DNA. The results show a significant (p . 0.001,
Fisher’s exact test) decrease in amounts of E-selectin mRNA in the prednisolone 1% and triamcinolone 0.1% treated areas (III and IV) versus area I treated with basic ointment
only. The differences between triamcinolone 0.1% treated area IV and hydrocortisone-treated area II additionally reach significance (p . 0.01, Fisher’s exact test).
selectin mRNA levels compared with the basic ointment Unguentum
leniens (p , 0.001, Fisher’s exact test) and hydrocortisone acetate
0.4% (p , 0.01, Fisher’s exact test). Comparison of hydrocortisone
versus basic ointment and triamcinolone versus prednisolone were
statistically borderline (p 5 0.071 and p 5 0.044, respectively,
Fisher’s exact test).
DISCUSSION
Several read-out systems have been established that try to evaluate
and quantitate the amount of cutaneous irritation and its correspond-
ing inflammatory response. Most studies are based on noninvasive
clinical and physiologic methods such as laser Doppler blood flow,
color reflectance (Wilhelm et al, 1989), clinical scoring (York et al,
1996), measurements of the transepidermal water loss (Iliev et al,
1997), or the skin redness (colorimetry). Sorption-desorption and
moisture accumulation tests were additionally considered to be
suitable to detect changes of the stratum corneum properties even
if there are no visible modifications of the skin (Treffel and
Gabard, 1996). These methods, however, all have a relatively high
interobserver variation or show a great variation from site to site
or from day to day (e.g., transepidermal water loss). Furthermore,
their exact correlation to the extent of the dermal inflammation
has not been established.
Other possible methods to evaluate directly the amount of
inflammation, e.g., counting of the number of inflammatory cells
or vessels positive for an inflammatory adhesion molecule such as
ICAM-1, VCAM-1, or E-selectin are time-consuming and may
greatly depend on which sections were chosen for staining and
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Table IV. Results of competitive reverse transcriptase–PCR for E-selectin with different treatment conditionsa
amol per µl mimic DNA Area I Area II Area III Area IV
SDS 12 h Pretreatment SDS 12 h Pretreatment with SDS 12 h Pretreatment SDS 12 h Pretreatment with
with basic ointment 5 h hydrocortisone 0.4% 5 h with prednisolone 1% 5 h triamcinolone 0.1% 5 h
0 2/10
7/10
10–4 5/10 3/10
10–3 1/10 5/10 3/10
10–2 4/10 5/10
0.5 3 10–2 3/10
10–1 2/10
aSkin biopsy specimens were obtained from the back of healthy individuals. All areas were irritated for 12 h with SDS 1% for 12 h and area II treated with hydrocortisone
0.4%, area III with prednisolone 1.0%, and area IV with triamcinolone 0.1% for 5 h. After RNA extraction and reverse transcription, competitive reverse transcriptase–PCR
was performed using defined concentrations of a preconstructed mimic DNA. The results show a significant (p . 0.001, Fisher’s exact test) decrease in the amount of E-
selectin mRNA in the prednisolone 1% and triamcinolone 0.1% (areas III and IV) versus area I treated with the basic ointment only. The differences between prednisolone
1.0% and triamcinolone 0.1% treated areas versus hydrocortisone-treated areas II additionally reach significance (p . 0.01, Fisher’s exact test). Comparison of triamcinolone
0.1% versus prednisolone 1.0% revealed lower statistical significance (p 5 0.044, Fisher’s exact test).
evaluation. Additionally, they may have a high interobserver
variation.
The aim of this study was therefore to develop a read-out system
that: (i) is observer independent; (ii) can be performed in different
laboratories using the same standardized protocol; (iii) evaluates the
whole biopsy specimen and not only single sections; and that (iv)
needs only small tissue samples.
The evaluation of the expression of the adhesion molecule E-
selectin was chosen for the following reasons: It is not expressed
in healthy skin, but can be found on the surface of dermal
endothelial cells in cutaneous inflammatory reactions (Groves
et al, 1991; Brasch et al, 1992; Henseleit et al, 1996). Some
immunohistochemical studies suggested a good correlation between
the expression of E-selectin on vessels and the amount of cutaneous
inflammation (von den Driesch et al, 1993; von den Driesch and
Simon, 1994). It is known that E-selectin is induced after challenge
of the epidermis with agents causing an irritant or allergic contact
dermatitis (Brasch et al, 1992; Friedmann et al, 1993). Another
group demonstrated upregulation of E-selectin after induction of
irritant or allergic contact dermatitis in a mouse model and found
a good correlation between E-selectin expression and the amount
of cutaneous inflammatory infiltrates (Henseleit et al, 1996).
To avoid an immunohistochemical evaluation of single sections
and to get representative data for the whole biopsy specimen, we
decided to monitor E-selectin mRNA regulation. Little is known
so far about the in vivo mRNA expression of E-selectin in cutaneous
irritation. We therefore established in a pilot study that by means
of a sensitive reverse transcriptase–PCR the occurence of E-selectin
mRNA can be demonstrated as soon as 30 min after the application
of SDS 1% on healthy epidermis and reaches a maximum at 4 h.
We found the corresponding protein expression 2–3 h after
application (unpublished data). To allow a comparison between
biopsy specimens from test areas treated with different modalities,
the establishment of a competitive reverse transcriptase–PCR was
essential. A similar method was recently used to quantitate mRNA
of several adhesion molecules (VCAM-1, ICAM-1, and E-selectin)
in skin biopsies taken from delayed-type hypersensitivity reactions
(Meagher et al, 1994).
In the first series of experiments, a commercially available
corticosteroid was chosen for which an identical basic ointment
could be obtained. As a result, we found no E-selectin mRNA in
untreated skin. It has to be kept in mind, however, that our subjects
did not suffer from any skin or systemic inflammatory disease. In
the biopsy specimens from skin irritated with SDS for 4 h, constant
amounts of wild-type E-selectin mRNA comparable with a level
of 10–2 amol per µl mimic DNA could be detected. These data
suggest that the amount of the endothelial activation was similar
between the 10 subjects tested. Topical preapplication of prednicarb-
ate 0.25% 12 h before application of the irritant yielded 10–100-
fold lower wild-type DNA concentrations. Again, the variation
between the 10 subjects tested was surprisingly low resulting in
clearly significant results. Application of the basic ointment showed
in eight cases no difference to the untreated biopsies, but in two
subjects even higher mRNA levels comparable with 10–1 amol
mimic DNA per µl. The frequency of this result was too low,
however, to reach significance but it has to be concluded at least
that no preventing potency of the basic ointment could be
demonstrated. An explanation for this phenomenon could be that
the basic ointment increased the penetration of the SDS.
The second and third series of experiments represent a comparison
of topical corticosteroids of different strength which were dissolved
in a standard basic ointment. Two models were used: (i) prevention
of irritation-induced E-selectin mRNA induction and (ii) suppres-
sion after irritation-induced induction. According to Guzzo et al
(1997), hydrocortisone acetate 0.4% belongs to group 6, predniso-
lone 1% to group 5, and triamcinolone acetonide 0.1% to group 3.
Our results of suppression of E-selectin mRNA induction correlates
well with these suggested strengths. The differences between the
group 3 and 5 corticosteroids and the basic ointment as well as the
difference between the group 3 and group 6 corticosteroids were
highly significant. There was additionally a trend for differences
between prednisolone and hydrocortisone and between triamcino-
lone and prednisolone, but the number of measurements was
presently too limited to reach clear significance. We believe from
our data, however, that optimizing the system question should
make it possible to work out even relatively small strength differ-
ences between topical anti-inflammatory drugs. It is mandatory,
however, to use the same basic ointment. Thus, a comparison of
the data of the first experiments with prednicarbate and the second
series with the three other corticosteroids was not reasonable.
This study shows that it is possible to evaluate a possible
anti-inflammatory effect of topically applied corticosteroids by
monitoring irritation-induced mRNA signals for E-selectin in vivo.
The method is invasive but due to the sensitivity of the reverse
transcriptase–PCR only very small tissue samples are needed. Done
routinely, this assay is not too time-consuming. We suggest this
approach to be a tool for the evaluation of the anti-inflammatory
potency of drugs applied topically to the skin.
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